Advangen develops scientifically validated hair loss products to treat various forms of hair loss. Advangen only sells products that have a well understood mechanism of action and been proven to work by independent scientific testing. Advangen’s discovery and product development processes are the same ones used to identify and test new medicines for treating human disease. Advangen’s products are placed under the same rigour and scrutiny normally reserved for pharmaceuticals and their mechanism of action is the subject of scientific publications. That is why we can confidently vouch for the safety and effectiveness of all our products.
View Top Employees from AdvangenWebsite | http://www.advangen.com.au |
Revenue | $6.6 million |
Employees | 4 (4 on RocketReach) |
Founded | 2010 |
Address | 1815 Castlereagh St L Ste 1802, Sydney, New South Wales 2000, AU |
Phone | +61 2 9233 8975 |
Industry | Biotechnology, Manufacturing General, Manufacturing |
Competitors | AGY Therapeutics, Inc., Keune Haircosmetics, ManRos Therapeutics, ReGen Therapeutics Plc, reMYND NV |
SIC | SIC Code 283 Companies, SIC Code 80 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Advangen employee's phone or email?
The Advangen annual revenue was $6.6 million in 2024.
Evan Rees is the Vice President of Advangen.
4 people are employed at Advangen.
Advangen is based in Sydney, New South Wales.
The NAICS codes for Advangen are [54, 541711, 5417, 54171, 541].
The SIC codes for Advangen are [283, 80, 28].